Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 62

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity

Tiosano, Dov, Eisentein, Israel, Militianu, Daniela, Chrousos, George P., Hochberg, Ze’ev · 2003 · The Journal of Clinical Endocrinology & Metabolism

Abstract

After extensive suprasellar operations for hypothalamic tumor removal, some patients develop Cushing-like morbid obesity while they receive replacement doses of glucocorticoids. In this study, we examined the hypothesis that target tissue conversion of inactive 11-ketosteroids to active 11β-OH glucocorticoids might explain the obesity of some patients with hypothalamic lesions. Toward this aim, we studied 10 patients with hypothalamic obesity and secondary adrenal insufficiency and 6 control Addisonian patients while they were on glucocorticoid replacement therapy. Pituitary hormone deficiencies were replaced when medically indicated. Twenty-four-hour urine was collected after a single oral dose of 12 mg/m2 hydrocortisone acetate. The ratios of free and conjugated cortisol (F) to cortisone (E) and their metabolites, [tetrahydrocortisol (THF)+5αTHF]/tetrahyrdocortisone (THE), dihydrocortisols/dihydrocortisones, cortols/cortolones, and (F+E)/(THF+THE+5αTHF), were considered to represent 11β-hydroxysteroid dehydrogenase (HSD) activity. The 11-OH/11-oxo ratios were significantly higher in the urine of patients with hypothalamic obesity. The 11-OH/11-oxo ratios, however, did not correlate with the degree of obesity, yet a significant correlation was found between conjugated F/E and the ratio of visceral fat to sc fat measured by computerized tomography at the umbilical level. The consequence of increased 11β-HSD1 activity and the shift of the interconversion toward cortisol may contribute to the effects of the latter in adipose tissue. We propose that deficiency of hypothalamic messengers after surgical injury induces a paracrine/autocrine effect of enhanced glucocorticoid activity due to up-regulated 11β-HSD1 activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2002-020511

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 23

  1. Gura, 2000, Tracing leptin’s partners in regulating body weight., Science, 287, 1738, 10.1126/science.287.5459.1738 · doi:10.1126/science.287.5459.1738
  2. Hoffman, 1992, Aggressive surgical management of craniopharyngiomas in children., J Neurosurg, 76, 47, 10.3171/jns.1992.76.1.0047 · DOI · Paper page
  3. Vile, 1996, Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging., J Clin Endocrinol Metab, 81, 2734
  4. Skorzewska, 1989, Abnormal food-seeking behavior after surgery for craniopharyngioma., Neuropsychobiology, 21, 17, 10.1159/000118545 · DOI
  5. Stewart, 1996, 11β-hydroxysteroid dehydrogenase: implications for clinical medicine., Clin Endocrinol (Oxf), 44, 493, 10.1046/j.1365-2265.1996.716535.x · DOI
  6. Ricketts, 1998, Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues., J Clin Endocrinol Metab, 83, 1325
  7. Rask, 2002, Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity., J Clin Endocrinol Metab, 87, 3330
  8. Tiosano, 1999, The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor., Thyroid, 9, 887, 10.1089/thy.1999.9.887 · DOI
  9. Sandrini, 2001, Spectrum of mutations of the AAAS gene and genotype-phenotype correlation in patient with isolated resistance to corticotropin or Allgrove syndrome., J Clin Endocrinol Metab, 86, 5433, 10.1210/jcem.86.11.8037 · DOI
  10. Weaver, 1998, Sexual dimorphism in 11 β hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects., Clin Endocrinol (Oxf), 49, 13, 10.1046/j.1365-2265.1998.00494.x · DOI
  11. Dunkelman, 1964, Cortisol metabolism in obesity., J Clin Endocrinol Metab, 24, 832, 10.1210/jcem-24-9-832 · DOI
  12. Andrew, 1998, Obesity and gender influence cortisol secretion and cortisol metabolism in man., J Clin Endocrinol Metab, 83, 1806, 10.1210/jcem.83.5.4951 · doi:10.1210/jcem.83.5.4951 · Paper page
  13. Rask, 2001, Tissue-specific disregulation of cortisol metabolism in human obesity., J Clin Endocrinol Metab, 86, 1418, 10.1210/jcem.86.3.7453 · doi:10.1210/jcem.86.3.7453 · Paper page
  14. Fraser, 1999, Cortisol effects on body mass, blood pressure, and cholesterol in the general population., Hypertension, 33, 1364, 10.1161/01.HYP.33.6.1364 · DOI · Paper page
  15. Reynolds, 2001, Altered control of cortisol secretion in adult men with low birthrate and cardiovascular risk factors., J Clin Endocrinol Metab, 86, 245
  16. Whorwood, 2002, Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome., Diabetes, 51, 1066, 10.2337/diabetes.51.4.1066 · DOI · Paper page
  17. Bujalska, 2002, A switch in dehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells., J Clin Endocrinol Metab, 87, 1205
  18. Friedberg, 2003, Modulation of 11β-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers., J Clin Endocrinol Metab, 88, 385, 10.1210/jc.2002-020510 · DOI
  19. Sorva, 1988, Elevate adipose tissue lipoprotein lipase activity in craniopharyngioma patients., Metabolism, 37, 418, 10.1016/0026-0495(88)90039-X · DOI
  20. Finken, 1999, Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductase but not 11-hydroxysteroid dehydrogenases., J Clin Endocrinol March, 84, 3316
  21. Whorwood, 1993, Tissue-specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase expression in the rat., J Steroid Biochem Mol Biol, 46, 539, 10.1016/0960-0760(93)90180-5 · DOI
  22. Hammami, 1991, Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action., J Clin Endocrinol Metab, 73, 326, 10.1210/jcem-73-2-326 · DOI
  23. Kotelevtsev, 1997, 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress., Proc Natl Acad Sci USA, 94, 14924, 10.1073/pnas.94.26.14924 · DOI · Paper page

Cited by

See all 62

Metadata

Authors
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., & Hochberg, Z.
Affiliations
  • Departments of Pediatrics (D.T., I.E., Z.H.), Haifa 31096, Israel
  • Radiology (D.M.), Meyer Children’s Hospital, Haifa 31096, Israel
  • National Institute of Child Health and Human Development, Pediatric and Reproductive Endocrinology Branch (G.P.C., Z.H.), Bethesda, Maryland 20892
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-01-01
Volume
88
Issue
1
Pages
379-384
ISSN
  • 0021-972X
  • 1945-7197
Cited by
62
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity. https://app.cochat.ai/papers/10.1210/jc.2002-020511
The paper
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., & Hochberg, Z. (2003). 11β-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2002-020511

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.